NCC Medical Group is an internationally recognized manufacturer and technology developer specializing in neurodiagnostic and neuro-monitoring equipment. As a nationally designated SRDI “Little Giant” enterprise, NCC represents a group of highly innovative companies recognized for their advanced technological capabilities and strong intellectual property foundations.
Founded in 1997, NCC has accumulated more than two decades of expertise in neurophysiology technology development and medical device manufacturing. The company’s primary research and manufacturing center is located in Shanghai, China, one of the most dynamic medical technology hubs in Asia.
At the Shanghai facility, multidisciplinary teams of biomedical engineers, neurophysiologists, and product specialists collaborate to design and produce advanced neurophysiology systems including Iom Monitoring equipment, EEG systems, polysomnography (PSG) platforms, electromyography (EMG) devices, and specialized neurophysiology medical consumables.
To ensure international product compliance and quality assurance, NCC operates a dedicated quality management and regulatory center in Singapore. This global hub manages international certifications, regulatory documentation, and product validation processes, ensuring that NCC devices meet international medical equipment standards.
NCC’s operational strategy is built around three core pillars designed to support global innovation and market expansion.
The first pillar focuses on research and manufacturing excellence. Continuous investment in research and engineering allows NCC to develop advanced neurophysiology technologies and maintain precision manufacturing standards.
The second pillar focuses on global sales and distribution development. Through strategic partnerships with international distributors and healthcare institutions, NCC has established a strong presence in markets across Southeast Asia, Europe, Australia, the Americas, and Africa.
The third pillar emphasizes clinical service and professional education. Through the NeuGuard Service Platform and the NCC Innovation Academy, the company provides training programs, technical workshops, and clinical education to healthcare professionals worldwide.
Today, NCC neurophysiology monitoring solutions are deployed in more than 50 countries and installed in over 5,000 hospitals across China. These technologies help surgeons perform safer procedures and allow clinicians to conduct accurate neurophysiology diagnostics.
To further support clinical adoption, NCC operates 31 technical training and support centers across China, providing hands-on education and technical assistance to clinicians, biomedical engineers, and healthcare institutions.
Guided by its mission “Safeguarding Life and Health,” NCC continues to develop innovative neurophysiology technologies that support safer surgical procedures, more accurate neurological diagnosis, and improved patient outcomes worldwide.
Copyright © NCC Medical Co., Ltd. - Privacy policy